Novel NPY2R agonist BI 1820237 provides synergistic anti-obesity efficacy when combined with the GCGR/GLP-1R dual agonist survodutide
新型NPY2R激动剂BI 1820237与GCGR/GLP-1R双重激动剂苏沃度肽联合使用时,可产生协同抗肥胖疗效。
期刊:Molecular Metabolism
影响因子:6.6
doi:10.1016/j.molmet.2025.102205
Augustin, Robert; Oldenburger, Anouk; Baader-Pagler, Tamara; Zimmermann, Tina; Borghardt, Jens; Hecksher-Sørensen, Jacob; Baljuls, Angela; Reindl, Wolfgang; Krawczyk, Bartlomiej; Martel, Eric; Brennauer, Albert; Peters, Stefan; Grube, Achim; Rudkjaer, Lise Biehl; Haebel, Peter